Open-label investigation of the pharmacokinetic profile, safety, tolerability, and efficacy of multiple administrations of tapentadol oral solution used for treatment of acute pain in children aged 2 years to less than 7 years
Latest Information Update: 04 Nov 2020
At a glance
- Drugs Tapentadol (Primary)
- Indications Acute pain
- Focus Pharmacokinetics
- Sponsors Grunenthal
Most Recent Events
- 29 Oct 2020 Status changed to completed.
- 03 Jul 2019 New trial record